Penicillin resistance of nonvaccine type pneumococcus before and after PCV13 introduction, United States

Cheryl P. Andam; Colin J. Worby; Ryan Gierke; Lesley McGee; Tamara Pilishvili; William P. Hanage

doi:10.3201/eid2306.161331

Penicillin resistance of nonvaccine type pneumococcus before and after PCV13 introduction, United States

Cheryl P. Andam
, Colin J. Worby
, Ryan Gierke
, Lesley McGee
, Tamara Pilishvili
, William P. Hanage

Biology

University at Albany

Harvard University
Centers for Disease Control and Prevention

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

Original language	English
Pages (from-to)	1012-1015
Number of pages	4
Journal	Emerging infectious diseases
Volume	23
Issue number	6
DOIs	https://doi.org/10.3201/eid2306.161331
State	Published - Jun 2017

Access to Document

10.3201/eid2306.161331

Cite this

@article{cdd123d5c9c347c6b16c913d99fe3f7d,

title = "Penicillin resistance of nonvaccine type pneumococcus before and after PCV13 introduction, United States",

abstract = "Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.",

author = "Andam, \{Cheryl P.\} and Worby, \{Colin J.\} and Ryan Gierke and Lesley McGee and Tamara Pilishvili and Hanage, \{William P.\}",

year = "2017",

month = jun,

doi = "10.3201/eid2306.161331",

language = "English",

volume = "23",

pages = "1012--1015",

journal = "Emerging infectious diseases",

issn = "1080-6040",

publisher = "Centers for Disease Control and Prevention (CDC)",

number = "6",

}

TY - JOUR

T1 - Penicillin resistance of nonvaccine type pneumococcus before and after PCV13 introduction, United States

AU - Andam, Cheryl P.

AU - Worby, Colin J.

AU - Gierke, Ryan

AU - McGee, Lesley

AU - Pilishvili, Tamara

AU - Hanage, William P.

PY - 2017/6

Y1 - 2017/6

N2 - Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

AB - Introduction of 13-valent pneumococcal conjugate vaccine in the United States was not associated with a significant change in prevalence of penicillin resistance in nonvaccine type serotypes because of the variable success of highly resistant serotypes. Differences in regional serotype distribution and serotype-specific resistance contributed to geographic heterogeneity of penicillin resistance.

UR - https://www.scopus.com/pages/publications/85019896788

U2 - 10.3201/eid2306.161331

DO - 10.3201/eid2306.161331

M3 - Article

C2 - 28518018

SN - 1080-6040

VL - 23

SP - 1012

EP - 1015

JO - Emerging infectious diseases

JF - Emerging infectious diseases

IS - 6

ER -

Penicillin resistance of nonvaccine type pneumococcus before and after PCV13 introduction, United States

Abstract

Access to Document

Other files and links

Fingerprint

Cite this